S. Huang, C. Chang, P. Cheng, C. Hsiao, Y. Soong et al., First-trimester combined screening is effective for the detection of unbalanced chromosomal translocations at 11 to 12 weeks of gestation, Reprod. Sci, vol.21, pp.594-600, 2014.

N. Torring, O. B. Petersen, N. Becher, I. Vogel, and N. Uldbjerg, First trimester screening for other trisomies than trisomy 21, 18, and 13, Prenat. Diagn, vol.35, pp.612-619, 2015.

A. Lindquist, A. Poulton, J. Halliday, and L. Hui, Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: Implications for contingent models of non-invasive prenatal testing, Ultrasound Obstet. Gynecol, vol.51, pp.487-492, 2018.

D. W. Bianchi and R. W. Chiu, Sequencing of Circulating Cell-free DNA during Pregnancy, N. Engl. J. Med, vol.379, pp.464-473, 2018.

F. Fiorentino, S. Bono, F. Pizzuti, S. Duca, A. Polverari et al., The clinical utility of genome-wide non invasive prenatal screening, Prenat. Diagn, vol.37, pp.593-601, 2017.

D. Liang, Y. Lin, F. Qiao, H. Li, Y. Wang et al., Perinatal outcomes following cell-free DNA screening in >32 000 women: Clinical follow-up data from a single tertiary center, Prenat. Diagn, vol.38, pp.755-764, 2018.

R. Akolekar, J. Beta, G. Picciarelli, C. Ogilvie, and F. Antonio, Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: A systematic review and meta-analysis, Ultrasound Obstet. Gynecol, vol.45, pp.16-26, 2015.

L. J. Salomon, A. Sotiriadis, C. B. Wulff, A. Odibo, and R. Akolekar, Risk of miscarriage following amniocentesis or chorionic villus sampling: Systematic review of literature and updated meta-analysis, Ultrasound Obstet. Gynecol, vol.54, pp.442-451, 2019.

T. Michael, S. Natalia, M. James, B. Jörg, N. Yuri et al., Mid-trimester preterm premature rupture of membranes (PPROM): Etiology, diagnosis, classification, international recommendations of treatment options and outcome, J. Perinat. Med, vol.46, pp.465-488, 2018.

M. Cederholm and B. Haglund, Axelsson, O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping, BJOG, vol.110, pp.392-399, 2003.

M. E. Norton, R. J. Baer, R. J. Wapner, M. Kuppermann, L. L. Jelliffe-pawlowski et al., Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities, Am. J. Obstet. Gynecol, vol.214, pp.1-6, 2016.

A. J. Sehnert, B. Rhees, D. Comstock, E. De-feo, G. Heilek et al., Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood, Clin. Chem, vol.57, pp.1042-1049, 2011.

M. Ehrich, C. Deciu, T. Zwiefelhofer, J. A. Tynan, L. Cagasan et al., Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting, Am. J. Obstet. Gynecol, vol.204, pp.1-11, 2011.

T. J. Jensen, T. Zwiefelhofer, R. C. Tim, Z. Dzakula, S. K. Kim et al., High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma, PLoS ONE, vol.8, 2013.

K. Juneau, P. E. Bogard, S. Huang, M. Mohseni, E. T. Wang et al., Microarray-based cell-free DNA analysis improves noninvasive prenatal testing, Fetal Diagn. Ther, vol.36, pp.282-286, 2014.

B. Zimmermann, M. Hill, G. Gemelos, Z. Demko, M. Banjevic et al., Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci, Prenat. Diagn, vol.32, pp.1233-1241, 2012.

E. Pergament, H. Cuckle, B. Zimmermann, M. Banjevic, S. Sigurjonsson et al., Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort, Obstet. Gynecol, vol.124, pp.210-218, 2014.

H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake, Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing, Clin. Chem, vol.56, pp.1279-1286, 2010.

Y. M. Lo, K. C. Chan, H. Sun, E. Z. Chen, P. Jiang et al., Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci. Transl

G. E. Palomaki and E. M. Kloza, Prenatal cell-free DNA screening test failures: A systematic review of failure rates, risks of Down syndrome, and impact of repeat testing, Genet. Med, vol.20, pp.1312-1323, 2018.

F. Jiang, J. Ren, F. Chen, Y. Zhou, J. Xie et al., Noninvasive Fetal Trisomy (NIFTY) test: An advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies, BMC Med. Genom, vol.5, 2012.

C. Liao, A. H. Yin, C. F. Peng, F. Fu, J. X. Yang et al., Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing, Proc. Natl. Acad. Sci, vol.111, pp.7415-7420, 2014.

M. Stumm, M. Entezami, K. Haug, C. Blank, M. Wustemann et al., Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: A collaborative study in Europe, Prenat. Diagn, vol.34, pp.185-191, 2014.

C. Samango-sprouse, M. Banjevic, A. Ryan, S. Sigurjonsson, B. Zimmermann et al., SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy, Prenat. Diagn, vol.33, pp.643-649, 2013.

A. R. Mazloom, Z. Dzakula, P. Oeth, H. Wang, T. Jensen et al., Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma, Prenat. Diagn, vol.33, pp.591-597, 2013.

J. Helgeson, J. Wardrop, T. Boomer, E. Almasri, W. B. Paxton et al., Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing, Prenat. Diagn, vol.35, pp.999-1004, 2015.

K. Martin, S. Iyengar, A. Kalyan, C. Lan, A. L. Simon et al., Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions, Clin. Genet, vol.93, pp.293-300, 2018.

K. R. Van-der-meij, E. A. Sistermans, M. V. Macville, S. J. Stevens, C. J. Bax et al., TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands, Am. J. Hum. Genet, vol.105, pp.1091-1101, 2019.

M. D. Pertile, M. Halks-miller, N. Flowers, C. Barbacioru, S. L. Kinnings et al., Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease, Sci. Transl. Med, vol.9, 2017.

G. Pescia, N. Guex, C. Iseli, L. Brennan, M. Osteras et al., Cell-free DNA testing of an extended range of chromosomal anomalies: Clinical experience with 6388 consecutive cases, Genet. Med, vol.19, pp.169-175, 2017.

A. De and L. Biomédecine, Rapport médical et scientifique de l'assistance médicale à la procréation et de la génétique humaines en France. In Prenatal Diagnosis and Preimplantation Genetic Diagnosis, p.23, 2017.

B. Bayindir, L. Dehaspe, N. Brison, P. Brady, S. Ardui et al., Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management, Eur. J. Hum. Genet, vol.23, pp.1286-1293, 2015.

D. Van-opstal, M. C. Van-maarle, K. Lichtenbelt, M. M. Weiss, H. Schuring-blom et al., Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: Results of the TRIDENT study, Genet. Med, vol.20, pp.480-485, 2018.

F. Scott, M. Bonifacio, R. Sandow, K. Ellis, M. E. Smet et al., Rare autosomal trisomies: Important and not so rare, Prenat. Diagn, vol.38, pp.765-771, 2018.

N. Chatron, M. Till, C. Abel, C. Bardel, F. Ramond et al., Detection of rare autosomal trisomies through non-invasive prenatal testing: Benefits for pregnancy management, Ultrasound Obstet. Gynecol, vol.53, pp.129-130, 2019.

A. J. Holland and D. W. Cleveland, Chromoanagenesis and cancer: Mechanisms and consequences of localized, complex chromosomal rearrangements, Nat. Med, vol.18, pp.1630-1638, 2012.

F. R. Grati, Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis, J. Clin. Med, vol.3, pp.809-837, 2014.

M. M. Gil, V. Accurti, B. Santacruz, M. N. Plana, and K. H. Nicolaides, Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis, Ultrasound Obstet. Gynecol, vol.50, pp.302-314, 2017.

S. De-wergifosse, E. Bevilacqua, I. Mezela, S. El-haddad, C. Gounongbe et al., Cell-free DNA analysis in maternal blood: Comparing genome-wide versus targeted approach as a first-line screening test, J. Matern. Fetal Neonatal Med, 2019.

F. R. Grati, J. Ferreira, P. Benn, C. Izzi, F. Verdi et al., Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA, Genet. Med, vol.22, pp.309-316, 2020.

K. Gadsbøll, O. B. Petersen, V. Gatinois, H. Strange, B. Jacobsson et al., Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation, Acta Obstet. Gynecol. Scand, vol.99, pp.722-730, 2020.

A. Benachi, J. Caffrey, P. Calda, E. Carreras, J. C. Jani et al., Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers, Eur. J. Med. Genet, vol.63, 2020.

M. Ehrich, J. Tynan, A. Mazloom, E. Almasri, R. Mccullough et al., Genome-wide cfDNA screening: Clinical laboratory experience with the first 10,000 cases, Genet. Med, vol.19, pp.1332-1337, 2017.

D. Liang, D. S. Cram, H. Tan, S. Linpeng, Y. Liu et al., Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes, Genet. Med, 2019.

Y. Xue, G. Zhao, H. Li, Q. Zhang, J. Lu et al., Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies, Mol. Cytogenet, vol.12, 2019.

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI